IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 48 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $130,825,939 | -13.4% | 2,520,731 | 0.0% | 0.75% | -13.8% |
| Q2 2023 | $151,143,031 | +21.3% | 2,520,731 | 0.0% | 0.88% | +29.1% |
| Q1 2023 | $124,624,941 | -13.4% | 2,520,731 | 0.0% | 0.68% | -21.5% |
| Q4 2022 | $143,858,118 | +21.6% | 2,520,731 | 0.0% | 0.86% | +11.5% |
| Q3 2022 | $118,323,000 | +25.8% | 2,520,731 | +0.0% | 0.78% | +45.1% |
| Q2 2022 | $94,048,000 | +24.8% | 2,520,730 | 0.0% | 0.53% | +23.3% |
| Q1 2022 | $75,370,000 | -12.7% | 2,520,730 | 0.0% | 0.43% | +3.1% |
| Q4 2021 | $86,310,000 | -7.6% | 2,520,730 | 0.0% | 0.42% | +2.4% |
| Q3 2021 | $93,443,000 | -5.1% | 2,520,730 | 0.0% | 0.41% | -5.1% |
| Q2 2021 | $98,435,000 | -8.3% | 2,520,730 | 0.0% | 0.43% | -7.1% |
| Q1 2021 | $107,307,000 | – | 2,520,730 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |